Although both calcineurin inhibitors increased urinary Mg excretion and caused hypomagnesemia shortly after HSCT, the effect was more significant with tacrolimus than with CSA. This observation may explain the higher incidence of renal impairment and encephalopathy in patients receiving tacrolimus.
No takes yet. Share an insight, caveat, or question.
Aisa et al. (2005) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: